| 产品描述: | EN106 is a potent inhibitor of FEMIB. EN106 is a cysteine-reactive covalent ligand. EN106 disrupts recognition of the key reductive stress substrate of FEM1B, FNIP1 |
| 体内研究: |
EN106 (HA-PBA-FA/EN106 hydrogel, topical application, 6 doses in 2 weeks) 在小鼠 Streptozotocin 诱发的 2 型糖尿病模型中促进伤口愈合,减少炎症反应,并促进血管生成。 |
| 参考文献: |
1. Henning NJ, et al. Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications. J Am Chem Soc. 2022;144(2):701-708. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.562 ml |
17.812 ml |
35.624 ml |
| 5 mM |
0.712 ml |
3.562 ml |
7.125 ml |
| 10 mM |
0.356 ml |
1.781 ml |
3.562 ml |
| 50 mM |
0.071 ml |
0.356 ml |
0.712 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |